Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.4M | $20.3M | $26.3M | $37.0M | $43.0M | $47.0M | $54.0M | $46.7M | $24.0M | $40.8M |
| Revenue growth | — | 24.2% | 29.5% | 40.6% | 16.3% | 9.3% | 15.0% | -13.6% | -48.6% | 69.8% |
| Gross profit | $7.67M | $10.3M | $12.7M | $18.5M | $22.6M | $23.4M | $27.3M | $21.8M | $10.2M | $17.0M |
| Gross margin | 46.9% | 50.6% | 48.4% | 49.9% | 52.6% | 49.8% | 50.5% | 46.6% | 42.4% | 41.6% |
| Operating income | -$1.59M | -$808K | -$1.48M | $3.14M | $6.04M | $1.08M | -$15.5M | -$11.0M | -$26.7M | -$16.8M |
| Operating margin | -9.7% | -4.0% | -5.6% | 8.5% | 14.0% | 2.3% | -28.7% | -23.5% | -111.3% | -41.2% |
| Net income | -$1.28M | -$877K | -$3.75M | $2.79M | $11.9M | $704K | -$16.2M | -$18.4M | -$31.7M | -$18.1M |
| Net margin | -7.8% | -4.3% | -14.2% | 7.5% | 27.6% | 1.5% | -30.0% | -39.4% | -132.2% | -44.4% |
| EPS (diluted) | -$0.04 | -$0.03 | -$0.12 | $0.08 | $0.35 | $0.02 | -$0.44 | -$0.50 | -$0.72 | -$0.40 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.15M | -$667K | $1.25M | $9.86M | $6.92M | $6.15M | $468K | -$9.59M | -$19.5M | -$8.76M |
| Capital expenditures | $162K | $182K | $626K | $343K | $140K | $208K | $381K | $239K | $191K | $255K |
| Free cash flow | -$1.31M | -$849K | $626K | $9.51M | $6.78M | $5.94M | $87.0K | -$9.83M | -$19.6M | -$9.02M |
| Share buybacks | $1.75M | — | $725K | $2.17M | $398K | $0.00 | $998K | $0.00 | — | — |
| Dividends paid | $955K | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13.5M | $12.8M | $11.1M | $18.8M | $23.3M | $13.2M | $12.7M | $8.66M | $4.95M | $7.97M |
| Total assets | $36.8M | $38.9M | $41.9M | $47.1M | $66.2M | $90.1M | $71.9M | $49.9M | $53.9M | $63.9M |
| Total liabilities | $2.24M | $3.67M | $8.37M | $11.7M | $17.0M | $24.2M | $21.5M | $16.1M | $36.4M | $61.7M |
| Long-term debt | — | — | $349K | $312K | $318K | $296K | $0.00 | — | — | — |
| Shareholders' equity | $34.6M | $35.2M | $33.5M | $35.4M | $49.1M | $66.0M | $50.4M | $33.8M | $17.6M | $2.17M |
| Retained earnings | -$51.9M | -$52.8M | -$56.5M | -$53.7M | -$41.9M | -$41.2M | -$57.4M | -$76.1M | -$108M | -$126M |
| Shares (wtd avg diluted) | 32.0M | 31.9M | 32.5M | 33.4M | 34.1M | 35.6M | 36.5M | 36.9M | 44.3M | 45.1M |
Every figure is extracted from Genasys Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.